Clay Johnston

Q: What Schools Are Affiliated With Clay Johnston

Clay Johnston is affiliated with the following schools: Capital Medical University, University of California, Berkeley, University of Texas at Austin, University of Oxford, University of California, Los Angeles, Amherst College, Cornell University, University of Toronto, Columbia University, University of California, San Francisco, Brown University, Jeju National University, Augusta University, Stanford University

Clay Johnston 's AcademicInfluence.com Rankings

Clay Johnston

Medical

#1308

Historical Rank

Epidemiology

#203

Historical Rank

medical Degrees

Clay Johnston

Philosophy

#7007

Historical Rank

Logic

#2788

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Clay Johnston 's Degrees

Doctorate Medicine University of California, San Francisco
PhD Epidemiology University of California, Berkeley

Why Is Clay Johnston Influential?

(Suggest an Edit or Addition)

According to Wikipedia, S. Claiborne "Clay" Johnston is the former Dean of the Dell Medical School and Frank and Charmaine Denius Distinguished Dean's Chair at the University of Texas, Austin, United States. Dell Medical School opened in 2016 with Johnston being named as the inaugural dean in January 2014 In July 2021, Johnston announced that he would step down as the dean of the Dell Medical School. He officially left his position on August 31, 2021.

(See a Problem?)

Clay Johnston 's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. (2014) (4138)
Forecasting the Future of Cardiovascular Disease in the United States: A Policy Statement From the American Heart Association (2011) (2450)
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. (2006) (2183)
2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association (2015) (2132)
The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. (2001) (1700)
Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the (2006) (1582)
Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. (2011) (1539)
Short-term prognosis after emergency department diagnosis of TIA. (2000) (1252)
Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack (2007) (1159)
Midlife cardiovascular risk factors and risk of dementia in late life (2005) (1136)
Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. (2013) (1052)
Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the (2006) (977)
Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling (2009) (947)
Clopidogrel and Aspirin in Acute Ischemic Stroke and High‐Risk TIA (2018) (657)
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. (2007) (625)
Forecasting the Future of Stroke in the United States: A Policy Statement From the American Heart Association and American Stroke Association (2013) (598)
Guidelines for the Management of Patients With Unruptured Intracranial Aneurysms: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association (2015) (572)
The burden, trends, and demographics of mortality from subarachnoid hemorrhage (1998) (551)
Effect of a Novel Free Radical Scavenger, Edaravone (MCI-186), on Acute Brain Infarction (2003) (534)
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. (2008) (490)
Predictors of Rehemorrhage After Treatment of Ruptured Intracranial Aneurysms: The Cerebral Aneurysm Rerupture After Treatment (CARAT) Study (2008) (429)
2015 AHA/ASA Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment (2015) (414)
Ischemic stroke risk with oral contraceptives: A meta-analysis. (2000) (403)
Recommendations for the Establishment of Stroke Systems of Care: Recommendations From the American Stroke Association's Task Force on the Development of Stroke Systems (2005) (379)
Risk of Recurrent Childhood Arterial Ischemic Stroke in a Population-Based Cohort: The Importance of Cerebrovascular Imaging (2007) (338)
Significance of Large Vessel Intracranial Occlusion Causing Acute Ischemic Stroke and TIA (2009) (333)
Risk of stroke in children (2003) (312)
Global Variation in the Relative Burden of Stroke and Ischemic Heart Disease (2011) (304)
Moyamoya disease in Washington State and California (2005) (303)
Recommendations for the Establishment of Stroke Systems of Care: Recommendations From the American Stroke Association’s Task Force on the Development of Stroke Systems (2005) (302)
Endovascular and surgical treatment of unruptured cerebral aneurysms: Comparison of risks (2000) (299)
Rates of Delayed Rebleeding From Intracranial Aneurysms Are Low After Surgical and Endovascular Treatment (2006) (296)
Hospital Usage of Early Do-Not-Resuscitate Orders and Outcome After Intracerebral Hemorrhage (2004) (296)
Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment (2015) (260)
Arterial dissection and stroke in children (2001) (254)
Incidence and mortality of generalized convulsive status epilepticus in California (2002) (249)
Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack. (2016) (248)
Longitudinal Risk of Intracranial Hemorrhage in Patients With Arteriovenous Malformation of the Brain Within a Defined Population (2004) (246)
Association Between CYP2C19 Loss-of-Function Allele Status and Efficacy of Clopidogrel for Risk Reduction Among Patients With Minor Stroke or Transient Ischemic Attack. (2016) (241)
Prevalence and knowledge of transient ischemic attack among US adults (2003) (241)
Secondary preventive medication persistence and adherence 1 year after stroke (2011) (239)
Treatment of unruptured cerebral aneurysms in California. (2001) (232)
Surgical and endovascular treatment of unruptured cerebral aneurysms at university hospitals (1999) (229)
Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA. (2020) (227)
The China National Stroke Registry for Patients with Acute Cerebrovascular Events: Design, Rationale, and Baseline Patient Characteristics (2011) (225)
Imaging Data Reveal a Higher Pediatric Stroke Incidence Than Prior US Estimates (2009) (215)
Incomplete Inhibition of Thromboxane Biosynthesis by Acetylsalicylic Acid: Determinants and Effect on Cardiovascular Risk (2008) (215)
Association Between Subarachnoid Hemorrhage Outcomes and Number of Cases Treated at California Hospitals (2002) (204)
Impact of hospital-related factors on outcome after treatment of cerebral aneurysms. (2003) (203)
National Stroke Association guidelines for the management of transient ischemic attacks (2006) (202)
Utilization of Intravenous Tissue-Type Plasminogen Activator for Ischemic Stroke at Academic Medical Centers: The Influence of Ethnicity (2001) (199)
Effect of endovascular services and hospital volume on cerebral aneurysm treatment outcomes. (2000) (190)
Evaluation of carotid stenosis using CT angiography in the initial evaluation of stroke and TIA (2004) (190)
Declining stroke rates in Californian children with sickle cell disease. (2004) (186)
How Accurate Is CT Angiography in Evaluating Intracranial Atherosclerotic Disease? (2008) (183)
Clopidogrel With Aspirin in Acute Minor Stroke or Transient Ischemic Attack (CHANCE) Trial: One-Year Outcomes (2015) (179)
Transient Ischemic Attack (2002) (177)
Spinal manipulative therapy is an independent risk factor for vertebral artery dissection (2003) (176)
Effect of a US National Institutes of Health programme of clinical trials on public health and costs (2006) (173)
Ten-Year Detection Rate of Brain Arteriovenous Malformations in a Large, Multiethnic, Defined Population (2010) (171)
Recommendations for the Endovascular Treatment of Intracranial Aneurysms: A Statement for Healthcare Professionals from the Committee on Cerebrovascular Imaging of the American Heart Association Council on Cardiovascular Radiology (2002) (171)
Recent advances in management of transient ischaemic attacks and minor ischaemic strokes (2006) (170)
Metrics for Measuring Quality of Care in Comprehensive Stroke Centers: Detailed Follow-Up to Brain Attack Coalition Comprehensive Stroke Center Recommendations: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association (2011) (167)
Addition of Brain Infarction to the ABCD2 Score (ABCD2I): A Collaborative Analysis of Unpublished Data on 4574 Patients (2010) (166)
Effect of Presenting Hemorrhage on Outcome after Microsurgical Resection of Brain Arteriovenous Malformations (2005) (162)
Predictors and Outcomes of Intraprocedural Rupture in Patients Treated for Ruptured Intracranial Aneurysms: The CARAT Study (2008) (161)
Deaths from stroke in US children, 1979 to 1998 (2002) (157)
Stroke Prognostication using Age and NIH Stroke Scale (2013) (148)
Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial (2017) (148)
The Transformational Effects of COVID-19 on Medical Education. (2020) (147)
Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: Rationale and design (2013) (146)
Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack. (2016) (145)
Safety and feasibility of a CT protocol for acute stroke: combined CT, CT angiography, and CT perfusion imaging in 53 consecutive patients. (2003) (145)
Long-Term Hemorrhage Risk in Children Versus Adults With Brain Arteriovenous Malformations (2005) (145)
The role of hypoventilation in a sheep model of epileptic sudden death (1995) (144)
C-Reactive Protein Levels and Viable Chlamydia pneumoniae in Carotid Artery Atherosclerosis (2001) (142)
Do the Brain Attack Coalition’s criteria for stroke centers improve care for ischemic stroke? (2005) (142)
Genetic Polymorphisms and Clopidogrel Efficacy for Acute Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis (2017) (140)
Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial (2017) (140)
External validation of the ICH score (2004) (138)
Reporting terminology for brain arteriovenous malformation clinical and radiographic features for use in clinical trials. (2001) (135)
Development and validation of outcome prediction models for aneurysmal subarachnoid haemorrhage: the SAHIT multinational cohort study (2018) (135)
Clinical- and Imaging-Based Prediction of Stroke Risk After Transient Ischemic Attack: The CIP Model (2009) (133)
Head Computed Tomography Findings Predict Short-Term Stroke Risk After Transient Ischemic Attack (2003) (131)
Breast vascular calcification and risk of coronary heart disease, stroke, and heart failure. (2004) (130)
Prognostic significance of angiographically confirmed large vessel intracranial occlusion in patients presenting with acute brain ischemia (2006) (128)
The iScore Predicts Effectiveness of Thrombolytic Therapy for Acute Ischemic Stroke (2012) (127)
Statin Use During Ischemic Stroke Hospitalization Is Strongly Associated With Improved Poststroke Survival (2012) (124)
Central apnea and acute cardiac ischemia in a sheep model of epileptic sudden death (1997) (122)
NIH Stroke Scale Reliability in Ratings from a Large Sample of Clinicians (2006) (121)
Reasons why few patients with acute stroke receive tissue plasminogen activator. (2006) (121)
Racial/Ethnic Differences in Longitudinal Risk of Intracranial Hemorrhage in Brain Arteriovenous Malformation Patients (2007) (120)
Alzheimer disease risk and genetic variation in ACE (2004) (117)
Which unruptured cerebral aneurysms should be treated? (1999) (116)
Design, Progress and Challenges of a Double-Blind Trial of Warfarin versus Aspirin for Symptomatic Intracranial Arterial Stenosis (2003) (116)
Cardiovascular risk management and its impact on hypertension control in primary care in low-resource settings: a cluster-randomized trial. (2010) (112)
The Importance of Cerebral Aneurysms in Childhood Hemorrhagic Stroke: A Population-Based Study (2009) (111)
Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials. (2019) (111)
Stent-Assisted Coiling versus Coiling Alone in Unruptured Intracranial Aneurysms in the Matrix and Platinum Science Trial: Safety, Efficacy, and Mid-Term Outcomes (2014) (108)
Higher ABCD2 Score Predicts Patients Most Likely to Have True Transient Ischemic Attack (2008) (108)
Bioactive versus Bare Platinum Coils in the Treatment of Intracranial Aneurysms: The MAPS (Matrix and Platinum Science) Trial (2014) (104)
Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack (2012) (102)
Frequency and determinants of pneumonia and urinary tract infection during stroke hospitalization. (2006) (102)
Epidemiology of Intracranial Stenosis (2009) (100)
Intracranial atherosclerotic disease: An update (2009) (100)
Application of the ABCD2 Score to Identify Cerebrovascular Causes of Dizziness in the Emergency Department (2012) (98)
Neurotoxicity of Intra-arterial Papaverine Preserved with Chlorobutanol Used for the Treatment of Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage (2004) (98)
Rate and predictors of serious neurologic causes of dizziness in the emergency department. (2012) (97)
Prevalence and Predictors of Perinatal Hemorrhagic Stroke: Results From the Kaiser Pediatric Stroke Study (2009) (97)
Early stroke risk and ABCD2 score performance in tissue- vs time-defined TIA (2011) (96)
Is hospitalization after TIA cost-effective on the basis of treatment with tPA? (2005) (96)
Rationale and design of a randomized, double-blind trial comparing the effects of a 3-month clopidogrel-aspirin regimen versus aspirin alone for the treatment of high-risk patients with acute nondisabling cerebrovascular event. (2010) (94)
Thirty-year projections for deaths from ischemic stroke in the United States. (2003) (92)
Dual antiplatelet therapy in stroke and ICAS (2015) (92)
Recent trauma and acute infection as risk factors for childhood arterial ischemic stroke (2012) (87)
Declining Diagnosis of Birth Asphyxia in California: 1991–2000 (2004) (87)
Urinary Tract Infections Complicating Stroke: Mechanisms, Consequences, and Possible Solutions (2010) (86)
The VASOGRADE: A Simple Grading Scale for Prediction of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage (2015) (86)
Ischemic Preconditioning From Transient Ischemic Attacks?: Data From the Northern California TIA Study (2004) (84)
The 5-year direct medical cost of neonatal and childhood stroke in a population-based cohort (2010) (84)
Why are eligible thrombolysis candidates left untreated? (2006) (82)
The learning curve for coil embolization of unruptured intracranial aneurysms. (2002) (79)
Risk of vascular events in emergency department patients discharged home with diagnosis of dizziness or vertigo. (2011) (79)
Cost-effectiveness of apixaban vs warfarin for secondary stroke prevention in atrial fibrillation (2012) (78)
Recurrent Hemorrhagic Stroke in Children: A Population-Based Cohort Study (2007) (78)
Tumor Necrosis Factor-&agr;–238G>A Promoter Polymorphism Is Associated With Increased Risk of New Hemorrhage in the Natural Course of Patients With Brain Arteriovenous Malformations (2006) (77)
Clinical practice. Transient ischemic attack. (2002) (77)
Practice patterns and outcomes after stroke across countries at different economic levels (INTERSTROKE): an international observational study (2018) (77)
Cost-Effectiveness of Outpatient Cardiac Monitoring to Detect Atrial Fibrillation After Ischemic Stroke (2010) (76)
Characteristics of Academic Medical Centers and Ischemic Stroke Outcomes (2001) (76)
Oral contraceptives and the risk of subarachnoid hemorrhage (1998) (74)
Impact of Social Distancing Measures on Coronavirus Disease Healthcare Demand, Central Texas, USA (2020) (74)
Association Between Major Perioperative Hemorrhage and Stroke or Q-Wave Myocardial Infarction (2012) (74)
Cognitive function predicts first-time stroke and heart disease (2005) (73)
Combining ecological and individual variables to reduce confounding by indication: case study--subarachnoid hemorrhage treatment. (2000) (73)
Effect of statin use during hospitalization for intracerebral hemorrhage on mortality and discharge disposition. (2014) (73)
Characteristics of Brain Arteriovenous Malformations With Coexisting Aneurysms: A Comparison of Two Referral Centers (2002) (71)
Regionalization of Treatment for Subarachnoid Hemorrhage: A Cost-Utility Analysis (2004) (71)
Modeling treatment effects on binary outcomes with grouped-treatment variables and individual covariates. (2002) (70)
Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial (2019) (69)
Effect of Clopidogrel plus ASA vs. ASA Early after TIA and Ischaemic Stroke: A Substudy of the CHARISMA Trial (2011) (69)
Pilot Randomized Trial of Outpatient Cardiac Monitoring After Cryptogenic Stroke (2013) (67)
Temporal and Geographic Trends in the Global Stroke Epidemic (2013) (64)
Are Patients With Acutely Recovered Cerebral Ischemia More Unstable? (2003) (63)
Early recovery after cerebral ischemia risk of subsequent neurological deterioration (2003) (61)
Recruiting Subjects for Acute Stroke Trials: A Meta-Analysis (2006) (61)
Profiles of lacunar and nonlacunar stroke (2011) (61)
Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA. (2021) (58)
National stroke association recommendations for systems of care for transient ischemic attack (2011) (58)
Initial Glasgow Coma Scale score predicts outcome following thrombolysis for posterior circulation stroke. (2005) (56)
Practice variation in neuroimaging to evaluate dizziness in the ED. (2012) (55)
Practice Variability in Management of Transient Ischemic Attacks (1999) (55)
A comparison of risk factors for recurrent TIA and stroke in patients diagnosed with TIA (2003) (53)
Delayed detection of atrial fibrillation after ischemic stroke. (2009) (52)
Dual Antiplatelet Therapy in Transient Ischemic Attack and Minor Stroke With Different Infarction Patterns: Subgroup Analysis of the CHANCE Randomized Clinical Trial (2018) (51)
Electrocardiographic findings predict short-term cardiac morbidity after transient ischemic attack. (2002) (50)
A Cost–Utility Analysis of Mechanical Thrombectomy as an Adjunct to Intravenous Tissue-Type Plasminogen Activator for Acute Large-Vessel Ischemic Stroke (2011) (50)
Stroke risk factors and loss of high cognitive function (2004) (49)
Anticipating and Training the Physician of the Future: The Importance of Caring in an Age of Artificial Intelligence. (2018) (48)
The influence of body mass index on mortality and bleeding among patients with or at high-risk of atherothrombotic disease. (2008) (48)
Consensus Conference on Intracranial Atherosclerotic Disease: Rationale, Methodology, and Results (2009) (48)
Inpatient statin use predicts improved ischemic stroke discharge disposition (2012) (47)
Tumor necrosis factor-alpha-238G>A promoter polymorphism is associated with increased risk of new hemorrhage in the natural course of patients with brain arteriovenous malformations. (2006) (46)
Estimated Association of Construction Work With Risks of COVID-19 Infection and Hospitalization in Texas (2020) (46)
High critical care usage due to pediatric stroke (2012) (46)
Early Outcomes After Carotid Artery Stenting Compared With Endarterectomy for Asymptomatic Carotid Stenosis (2015) (46)
Statins (2009) (45)
Neutrophil counts, neutrophil ratio, and new stroke in minor ischemic stroke or TIA (2018) (44)
Distinctive RNA Expression Profiles in Blood Associated With White Matter Hyperintensities in Brain (2010) (44)
The AWOL tool: derivation and validation of a delirium prediction rule. (2013) (44)
Should the Babinski sign be part of the routine neurologic examination? (2005) (44)
Prevalence, knowledge, and treatment of transient ischemic attacks in China (2015) (43)
Gender Differences in Treatment of Severe Carotid Stenosis After Transient Ischemic Attack (2010) (43)
Recurrent Stroke was Associated with Poor Quality of Life in Patients with Transient Ischemic Attack or Minor Stroke: Finding from the CHANCE Trial (2014) (42)
Identifying confounding by indication through blinded prospective review. (2001) (42)
Association of Lp-PLA2-A and early recurrence of vascular events after TIA and minor stroke (2015) (42)
A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. (2005) (40)
Statin Adherence Is Associated With Reduced Recurrent Stroke Risk in Patients With or Without Atrial Fibrillation (2017) (39)
Validation and refi nement of scores to predict very early stroke risk after transient ischaemic attack (2007) (38)
Effect of clopidogrel with aspirin on functional outcome in TIA or minor stroke (2015) (38)
Accuracy of Neurovascular Fellows' Prognostication of Outcome After Subarachnoid Hemorrhage (2012) (38)
Intracranial Large Vessel Occlusion as a Predictor of Decline in Functional Status After Transient Ischemic Attack (2011) (38)
Natalizumab in acute ischemic stroke (ACTION II) (2020) (38)
Time Course for Benefit and Risk of Clopidogrel and Aspirin after Acute Transient Ischemic Attack and Minor Ischemic Stroke: A Secondary Analysis from the POINT Randomized Trial. (2019) (38)
Apolipoprotein E ϵ2 Is Associated with New Hemorrhage Risk in Brain Arteriovenous Malformations (2006) (38)
Chlamydia pneumoniae Burden in Carotid Arteries Is Associated With Upregulation of Plaque Interleukin-6 and Elevated C-Reactive Protein in Serum (2005) (37)
Standardized discharge orders after stroke: Results of the quality improvement in stroke prevention (QUISP) cluster randomized trial (2010) (37)
Recurrent Stroke in Minor Ischemic Stroke or Transient Ischemic Attack With Metabolic Syndrome and/or Diabetes Mellitus (2017) (37)
Methylenetetrahydrofolate reductase C677T polymorphism and cognitive function in older women. (2007) (37)
Comparison of 2 approaches for determining the natural history risk of brain arteriovenous malformation rupture. (2010) (36)
Predicting Clinical Outcomes After Thrombolysis Using the iScore: Results From the Virtual International Stroke Trials Archive (2013) (36)
Deaths from stroke in US young adults, 1989–2009 (2014) (36)
Ischemic Transient Neurological Events Identified by Immune Response to Cerebral Ischemia (2012) (36)
4‐aminopyridine: New life for an old drug (2010) (36)
Pediatric Stroke Belt: Geographic Variation in Stroke Mortality in US Children (2004) (35)
Influence of physician specialty on outcomes after acute ischemic stroke. (2008) (35)
Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin (2020) (35)
The TEAM trial: Safety and efficacy of endovascular treatment of unruptured intracranial aneurysms in the prevention of aneurysmal hemorrhages: A randomized comparison with indefinite deferral of treatment in 2002 patients followed for 10 years (2008) (35)
Stress Hyperglycemia and Prognosis of Minor Ischemic Stroke and Transient Ischemic Attack: The CHANCE Study (Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events) (2017) (35)
Hormone therapy and the risk of stroke after acute myocardial infarction in postmenopausal women. (2001) (35)
Detection of atrial fibrillation after stroke and the risk of recurrent stroke. (2012) (33)
Clinical outcomes according to permanent discontinuation of clopidogrel or placebo in the CHARISMA trial. (2009) (33)
ASSOCIATION OF TUMOR NECROSIS FACTOR‐α–238G>A AND APOLIPOPROTEIN E2 POLYMORPHISMS WITH INTRACRANIAL HEMORRHAGE AFTER BRAIN ARTERIOVENOUS MALFORMATION TREATMENT (2007) (33)
Nighttime delivery and risk of neonatal encephalopathy. (2011) (33)
Effect of Clopidogrel on the Rate and Functional Severity of Stroke Among High Vascular Risk Patients: A Prespecified Substudy of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) Trial (2010) (32)
Patent foramen ovale closure--closing the door except for trials. (2012) (31)
A Systemic Network for Chlamydia pneumoniae Entry into Human Cells (2010) (30)
Unruptured intracranial aneurysms: the unreliability of clinical judgment, the necessity for evidence, and reasons to participate in a randomized trial. (2006) (30)
Is Mechanical Clot Removal or Disruption a Cost-Effective Treatment for Acute Stroke? (2011) (30)
Adjustment for do-not-resuscitate orders reverses the apparent in-hospital mortality advantage for minorities. (2005) (29)
Knowledge and management of transient ischemic attacks among US primary care physicians (2003) (29)
Ticagrelor in Acute Stroke or Transient Ischemic Attack in Asian Patients: From the SOCRATES Trial (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes) (2017) (29)
Association of Carotid Plaque Lp-PLA2 with Macrophages and Chlamydia pneumoniae Infection among Patients at Risk for Stroke (2010) (29)
Risks and benefits of clopidogrel–aspirin in minor stroke or TIA (2017) (29)
The Subarachnoid Hemorrhage International Trialists (SAHIT) Repository: Advancing Clinical Research in Subarachnoid Hemorrhage (2014) (29)
Acute Stroke or Transient Ischemic Attack Treated with Aspirin or Ticagrelor and Patient Outcomes (Socrates) Trial: Rationale and Design (2015) (28)
Antihypertensive Medications Prescribed at Discharge After an Acute Ischemic Cerebrovascular Event (2005) (28)
Obstacles to primary stroke prevention in children with sickle cell disease (2006) (28)
Oral contraceptives and stroke risk: the debate continues (2004) (27)
Predicting Clinical Outcomes and Response to Thrombolysis in Acute Stroke Patients With Diabetes (2013) (27)
Interobserver variability in grading of brain arteriovenous malformations using the Spetzler-Martin system. (2005) (27)
Disability after minor stroke and TIA (2019) (26)
Validation of the Stroke Prognostic Instrument-II in a Large, Modern, Community-Based Cohort of Ischemic Stroke Survivors (2011) (26)
Apolipoprotein E epsilon 2 is associated with new hemorrhage risk in brain arteriovenous malformations. (2006) (26)
Rapid development of giant fusiform cerebral aneurysms in angiographically normal vessels (1998) (25)
The iScore predicts efficacy and risk of bleeding in the National Institute of Neurological disorders and Stroke Tissue Plasminogen Activator Stroke Trial. (2013) (25)
The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design (2019) (25)
Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes) (2017) (25)
Transient ischemic attacks: stratifying risk. (2006) (25)
The thickness of the temporal squama and its implication for transcranial sonography. (2004) (25)
Short-term prognosis after a TIA: a simple score predicts risk. (2007) (24)
Cost‐Effectiveness of Clopidogrel‐Aspirin Versus Aspirin Alone for Acute Transient Ischemic Attack and Minor Stroke (2014) (24)
An Innovative Approach to Transposition Surgery is Effective in Treatment of Duane's Syndrome With Esotropia (2006) (24)
Association Between ABCB1 Polymorphisms and Outcomes of Clopidogrel Treatment in Patients With Minor Stroke or Transient Ischemic Attack: Secondary Analysis of a Randomized Clinical Trial (2019) (24)
Multiple stable fusiform intracranial aneurysms following atrial myxoma (2005) (24)
Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical Trial. (2019) (24)
A Comprehensive System for Pterygium Classification (2004) (23)
The Economic Case for New Stroke Thrombolytics (2010) (23)
Treatment Effect of Clopidogrel Plus Aspirin Within 12 Hours of Acute Minor Stroke or Transient Ischemic Attack (2016) (23)
Secondary-prevention drug prescription in the very elderly after ischemic stroke or TIA (2006) (22)
Regional variation in hospitalization for stroke among Asians/Pacific Islanders in the United States: a nationwide retrospective cohort study (2005) (22)
Poststroke Neurological Improvement Within 7 Days Is Associated With Subsequent Deterioration (2004) (22)
Duration of hospital participation in a nationwide stroke registry is associated with improved quality of care (2006) (22)
Impact of CYP2C19 polymorphism in prognosis of minor stroke or TIA patients with declined eGFR on dual antiplatelet therapy: CHANCE substudy (2018) (22)
Association of multiple infarctions and ICAS with outcomes of minor stroke and TIA (2017) (22)
Screen failure data in clinical trials: Are screening logs worth it? (2014) (21)
Clopidogrel with aspirin in High-risk patients with Acute Non-disabling Cerebrovascular Events II (CHANCE-2): rationale and design of a multicentre randomised trial (2019) (21)
The Use of Neuroimaging Studies and Neurological Consultation to Evaluate Dizzy Patients in the Emergency Department (2013) (21)
Race and sex disparities in prehospital recognition of acute stroke. (2015) (21)
Chronic dyspnea and hyperventilation in an awake patient with small subcortical infarcts (2001) (21)
Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack (2019) (21)
Decision making in acute stroke care: learning from neuroeconomics, neuromarketing, and poker players. (2014) (20)
Editorial comment--transient ischemic attacks are emergencies. (2005) (20)
Efficacy and Safety of Ticagrelor in Relation to Aspirin Use Within the Week Before Randomization in the SOCRATES Trial (2018) (20)
Elevated Neutrophil and Presence of Intracranial Artery Stenosis Increase the Risk of Recurrent Stroke (2018) (20)
High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: a substudy from the CHARISMA trial (2011) (19)
Evaluation and management of transient ischemic attack: an important component of stroke prevention (2007) (19)
Early editorial manuscript screening versus obligate peer review: A randomized trial (2007) (19)
Tortuosity of arterioles and venules in quantifying plus disease. (2009) (19)
Ticagrelor Versus Aspirin in Acute Embolic Stroke of Undetermined Source (2017) (18)
Transient ischemic attack: A neurologic emergency (2005) (18)
Trial on endovascular treatment of unruptured aneurysms (TEAM): study monitoring and rationale for trial interruption or continuation. (2007) (17)
Unruptured intracranial aneurysms and the Trial on Endovascular Aneurysm Management (TEAM): The principles behind the protocol. (2008) (17)
A simple risk index and thrombolytic treatment response in acute ischemic stroke. (2014) (17)
Diffusion-weighted MRI in evaluation of transient ischemic attack. (2003) (17)
Disability After Minor Stroke and Transient Ischemic Attack in the POINT Trial (2020) (16)
Endovascular Thrombectomy for Ischemic Stroke: The Second Quantum Leap in Stroke Systems of Care? (2016) (16)
Endogenous opioids modulate fetal rabbit lung maturation. (1987) (16)
Academic Medical Centers: Too Large for Their Own Health? (2019) (16)
Efficacy of Clopidogrel for Prevention of Stroke Based on CYP2C19 Allele Status in the POINT Trial (2020) (15)
Lipid assessment and treatment patterns in hospitalized TIA and ischemic stroke patients. (2006) (15)
Improved Ischemic Stroke Outcome Prediction Using Model Estimation of Outcome Probability: The THRIVE-c Calculation (2015) (15)
Factors Associated With the Decision to Hospitalize Patients After Transient Ischemic Attack Before Publication of Prediction Rules (2008) (15)
Design of COVID-19 Staged Alert Systems to Ensure Healthcare Capacity with Minimal Closures (2020) (15)
Marketing and drug costs: Who is laughing and crying? (2007) (15)
Balancing risk and reward: The question of natalizumab (2009) (15)
The beautiful and ethereal neurological exam: An appeal for research (2011) (15)
Effect of Estimated Glomerular Filtration Rate Decline on the Efficacy and Safety of Clopidogrel With Aspirin in Minor Stroke or Transient Ischemic Attack: CHANCE Substudy (Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events) (2016) (15)
Fighting decision fatigue (2012) (15)
genetic Polymorphisms and clopidogrel efficacy for acute ischemic stroke or transient ischemic attack (2016) (14)
Time to Retire the Concept of Transient Ischemic Attack. (2022) (14)
Distinguishing Intracerebral Hemorrhages Caused by Arteriovenous Malformations (2003) (14)
Ticagrelor Added to Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack in Prevention of Disabling Stroke (2020) (14)
Real-time pandemic surveillance using hospital admissions and mobility data (2022) (14)
Effect of English Proficiency and Research Funding on Acceptance of Submitted Articles to Stroke Journal (2014) (13)
Trends in Usage of Alternative Antiplatelet Therapy After Stroke and Transient Ischemic Attack (2008) (13)
A peek behind the curtain: Peer review and editorial decision making at Stroke (2014) (12)
Translation: Case study in failure (2006) (12)
Risk of Stroke after Transient Ischemic Attack or Minor Stroke. (2016) (12)
Association of Black Race With Early Recurrence After Minor Ischemic Stroke or Transient Ischemic Attack: Secondary Analysis of the POINT Randomized Clinical Trial. (2020) (12)
Is the NIHSS Certification Process Too Lenient? (2009) (12)
Effect of Clopidogrel by Smoking Status on Secondary Stroke Prevention. (2017) (12)
Basic and clinical research: What is the most appropriate weighting in a public investment portfolio? (2006) (11)
Oxidized low-density lipoprotein predicts recurrent stroke in patients with minor stroke or TIA (2018) (11)
Effects of the September 11th attacks on urgent and emergent medical evaluations in a Northern California managed care plan. (2002) (11)
Transient neurological attack: a useful concept? (2007) (11)
Design of COVID-19 staged alert systems to ensure healthcare capacity with minimal closures (2021) (11)
Unruptured intracranial aneurysms: their illusive natural history and why subgroup statistics cannot provide normative criteria for clinical decisions or selection criteria for a randomized trial. (2008) (11)
Does all single infarction have lower risk of stroke recurrence than multiple infarctions in minor stroke? (2019) (11)
Race-ethnicity on blood pressure control after ischemic stroke: a prospective cohort study. (2017) (11)
The challenge of publishing newsworthy epidemiology (2010) (11)
Caring Wisely: A Program to Support Frontline Clinicians and Staff in Improving Healthcare Delivery and Reducing Costs. (2017) (11)
Methodologies for pragmatic and efficient assessment of benefits and harms: Application to the SOCRATES trial (2020) (11)
Clinical trials: rising costs limit innovation (2007) (10)
Multiple sclerosis drugs: Sticker shock (2012) (10)
Regional differences in emergency medical services use for patients with acute stroke (findings from the National Hospital Ambulatory Medical Care Survey Emergency Department Data File). (2013) (10)
Impact of Increased Early Statin Administration on Ischemic Stroke Outcomes: A Multicenter Electronic Medical Record Intervention (2016) (10)
Five-year results of randomized bioactive versus bare metal coils in the treatment of intracranial aneurysms: the Matrix and Platinum Science (MAPS) Trial (2020) (10)
Interobserver Variability in Grading of Brain Arteriovenous Malformations Using the Spetzler-Martin System (2005) (10)
Intracranial Hemorrhage During Dual Antiplatelet Therapy: JACC Review Topic of the Week. (2021) (10)
T2 clinical research: Judgment day (2008) (10)
Cerebral small vessel disease or intracranial large vessel atherosclerosis may carry different risk for future strokes (2020) (10)
Crowdsourcing scientific innovation (2009) (10)
Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial (2019) (9)
Scripts for science: A new wrinkle on academic ties with industry (2008) (9)
Cocooning is essential to relaxing social distancing (2020) (9)
Urgent neurology consultation from the ED for transient ischemic attack. (2011) (9)
Comparative Effectiveness of Aspirin and Clopidogrel Versus Aspirin in Acute Minor Stroke or Transient Ischemic Attack (2018) (9)
Impact of Social Distancing Measures on COVID-19 Healthcare Demand in Central Texas (2020) (9)
Comparative effectiveness research in the neurosciences (2009) (9)
Added Benefit of Stent Retriever Technology for Acute Ischemic Stroke: A Pooled Analysis of the NINDS tPA, SWIFT, and STAR Trials. (2015) (9)
Transient ischemic attacks are emergencies (2005) (8)
Who belongs inside the carotid arteries? (2005) (8)
Personalized genetic scans: With gifts like these… (2009) (8)
Prognostication matters. (2000) (8)
AHA Policy Statement Forecasting the Future of Cardiovascular Disease in the United States A Policy Statement From the American Heart Association (2011) (8)
Nighttime delivery and risk of neonatal encephalopathy (2011) (8)
Nighttime delivery and risk of neonatal encephalopathy (2011) (8)
Outcome Assessment by Central Adjudicators Versus Site Investigators in Stroke Trials: A Systematic Review and Meta-Analysis. (2019) (8)
Fred Plum (1924–2010) and the founding of the Annals of Neurology (2010) (8)
Transient ischemic attack: a dangerous Harbinger and an opportunity to intervene. (2005) (7)
A status report on neuroscience research, without grade inflation (2006) (7)
Estimated treatment effect of ticagrelor versus aspirin by investigator-assessed events compared with judgement by an independent event adjudication committee in the SOCRATES trial (2019) (7)
Prevention of stroke following transient ischemic attack. (2011) (7)
Carotid Stenosis and Recurrent Ischemic Stroke (2021) (7)
Translational research for a new administration: What sort of change to believe in? (2008) (6)
Feasibility study to assess the use of the Cincinnati stroke scale by emergency medical dispatchers: a pilot study (2011) (6)
Heart Association / American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke (2015) (6)
Oxidative lipoprotein markers predict poor functional outcome in patients with minor stroke or transient ischaemic attack (2019) (6)
Applying principles from the game theory to acute stroke care: Learning from the prisoner’s dilemma, stag-hunt, and other strategies (2016) (6)
Neurology and medical devices (2006) (6)
Geographic Differences in Endovascular Treatment and Retreatment of Cerebral Aneurysms (2016) (6)
The dangers of clinical conviction: An “M&M” of endovascular therapies for stroke (2013) (6)
Stroke Journal: What Is Being Published to Advance the Field? (2013) (6)
Diagnosis and prognosis unclear for scientific manuscripts (2011) (6)
A Cross-Sectional Study of Individuals Seeking Information on Transient Ischemic Attack and Stroke Symptoms Online: A Target for Intervention? (2012) (6)
Efficacy and Safety of Ticagrelor and Aspirin in Patients With Moderate Ischemic Stroke (2021) (6)
Antiplatelet Use and Ischemic Stroke Risk in Minor Stroke or Transient Ischemic Attack: A Post Hoc Analysis of the POINT Trial (2021) (6)
Modern care for neurological problems must address waste (2012) (6)
Bilateral Sudden Hearing Loss in Waldenstrom's Macroglobulinemia: MR Appearance (2015) (6)
Clopidogrel with aspirin in minor stroke or transient ischemic attack. (2013) (5)
Electronic medical records and the academic neurologist: When carrots turn into sticks (2012) (5)
Can industry rescue the National Institutes of Health? (2006) (5)
Influence of smoking on CYP2C19 genetic variants and clopidogrel efficacy in patients with minor stroke or transient ischaemic attack (2019) (5)
The US Training System for Physicians—Need for Deeper Analysis (2018) (5)
Getting youth in the game: Can we accelerate training for clinician‐scientists? (2010) (5)
Prevention of Stroke Following Transient Ischemic Attack (2011) (5)
Leaving Tiny, Unruptured Intracranial Aneurysms Untreated: Why Is It So Hard? (2018) (5)
Evaluation of Systolic Blood Pressure, Use of Aspirin and Clopidogrel, and Stroke Recurrence in the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke Trial (2021) (5)
Matriculating the next generation of clinician‐scientists (2007) (5)
Effects of Cocooning on Coronavirus Disease Rates after Relaxing Social Distancing (2020) (5)
The 2008 William M. Feinberg lecture: prioritizing stroke research. (2008) (5)
Disability-Related Questions for Administrative Datasets (2020) (5)
Electronic medical records: Does it take a village or a thousand points of light? (2008) (5)
Twinning hearts and minds (2004) (4)
Learning From Neuroeconomics, Neuromarketing, and Poker Players Decision Making in Acute Stroke Care Comments and Opinions (2014) (4)
P2Y12 Inhibitors Plus Aspirin Versus Aspirin Alone in Patients With Minor Stroke or High-Risk Transient Ischemic Attack (2021) (4)
Abstract 182: Death and Disability after Coil Embolization of Ruptured and Unruptured Aneurysms in the Matrix And Platinum Science (MAPS) Trial (2012) (4)
Higher early recurrence risk and potential benefit of dual antiplatelet therapy for minor stroke with watershed infarction: subgroup analysis of CHANCE (2020) (4)
Epidemiology in the Annals: part of the problem or the solution? (2007) (4)
Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack (2021) (4)
Towards FASTER treatment of TIA and minor stroke (2007) (4)
Transformative research (2008) (4)
Florbetapir: Knowing one's future (2012) (4)
IOM task impossible: Set the agenda for neurological comparative effectiveness research (2009) (4)
The neurologic revolving door: Time to pay attention to readmissions (2013) (4)
DSM‐V: Psychodrama on the public stage (2013) (3)
Restart TICrH Trial Design: an adaptive randomized trial of time intervals to restart direct oral anticoagulants after traumatic intracranial hemorrhage. (2021) (3)
Of ghosts and sirens: The subtlest lures of industry (2007) (3)
Potassium, stroke, and the bounds of epidemiological studies (2001) (3)
Status report: The Annals in 2010 (2010) (3)
Safety and Speed of a CT Imaging Protocol for the Entire Cerebrovascular Axis During Acute Stroke (2001) (3)
Economic Over‐Stimulation? (2009) (3)
Time Course for Benefit and Risk With Ticagrelor and Aspirin in Individuals With Acute Ischemic Stroke or Transient Ischemic Attack Who Carry CYP2C19 Loss-of-Function Alleles: A Secondary Analysis of the CHANCE-2 Randomized Clinical Trial. (2022) (3)
Time to Loading Dose and Risk of Recurrent Events in the SOCRATES Trial (2019) (3)
Lp-PLA2 and dual antiplatelet agents in intracranial arterial stenosis (2019) (3)
Prognostication matters (2000) (3)
No Significant Relationship Between Ticagrelor and Sleep Apnea in Large, Randomized, Blinded Trials. (2020) (3)
Review: in-hospital care pathways for acute stroke do not improve clinical outcomes and lower quality of life. (2002) (3)
Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack (2022) (3)
Recombinant therapeutics: From bench to bedside (if your health plan concurs) (2006) (3)
That vexing problem of compensation (2008) (3)
Extraordinary claims require extraordinary evidence (2011) (3)
Can machine learning augment clinician adjudication of events in cardiovascular trials? A case study of major adverse cardiovascular events (MACE) across CVRM trials (2021) (3)
AHA/ASA Scientific Statement Definition and Evaluation of Transient Ischemic Attack (2009) (3)
Ischemic Attack: A Guideline for Healthcare Professionals From the American Guidelines for the Prevention of Stroke in Patients With Stroke or Transient (2011) (2)
Neuromuscular disease: Evidence and analysis in clinical neurology (2007) (2)
The neurological exam: Striking a nerve (2012) (2)
Contribution Methylenetetrahydrofolate Reductase C 677 T Polymorphism and Cognitive Function in Older Women (2007) (2)
Research trainees in the clinical neurosciences: Still a shallow pool (2009) (2)
Big neuroscience (2013) (2)
Regionalization of Treatment for Subarachnoid Hemorrhage (2004) (2)
Reliability of angiographic assessment of brain arteriovenous malformations. (2002) (2)
Stroke prediction after TIA: avoiding an alphabet soup (2010) (2)
Abstract 2721: Probabilistic Matching of Computerized Emergency Medical Services (EMS) records and Emergency Department and Patient Discharge Data: a Novel Approach to Evaluation of Prehospital Stroke Care (2012) (2)
Searching for novelty: Challenges with open access data (2012) (2)
Hyperglycemia, Risk of Subsequent Stroke, and Efficacy of Dual Antiplatelet Therapy: A Post Hoc Analysis of the POINT Trial (2022) (2)
Bilateral Evisceration : A Case Report (2006) (2)
The Economic Case for New Stroke (2010) (2)
A status report on the Annals (2008) (2)
Manuscripts, Referees, and Editors (2010) (2)
The Value of a Case Report (2007) (2)
F2R Polymorphisms and Clopidogrel Efficacy and Safety in Patients With Minor Stroke or TIA (2020) (2)
Global clinical trials: Challenges ahead (2011) (2)
Bleeding Risk of Dual Antiplatelet Therapy after Minor Stroke or Transient Ischemic Attack (2021) (2)
Peer review at National Institutes of Health: Small steps forward (2008) (2)
Neuroreconciliation and the health care debate (2010) (2)
Rate of progression differs in frontotemporal dementia and Alzheimer disease. Authors' reply (2006) (2)
Neurological disease on the global agenda (2008) (2)
Abstract TMP20: Efficacy and Safety of Ticagrelor in Relation to Prior Aspirin Usage in the SOCRATES Trial (2017) (1)
The Importance of the Electrocardiogram in TIA Evaluation (2001) (1)
Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial (2022) (1)
Abstract 172: Cost-Effectiveness of Dabigatran Compared with Warfarin for Secondary Stroke Prevention in Patients with Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack (2012) (1)
Effect of Hypertension on Efficacy and Safety of Ticagrelor-Aspirin Versus Clopidogrel-Aspirin in Minor Stroke or Transient Ischemic Attack (2022) (1)
Is hypertension the key to reaching the healthy people 2000 goals by 2020? (2013) (1)
Abstract WP119: Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial (2013) (1)
Letter by Elkins et al regarding article, "blocking of α4 integrin does not protect from acute ischemic stroke in mice". (2014) (1)
Neurologic Complications of Hypertension (2021) (1)
Diagnosis and prognosis of transient ischemic attacks (2004) (1)
Characteristics of Academic Medical Centers Associated with Ischemic Stroke Outcome (2000) (1)
The NIH shuffle, NCATS, and neurology (2011) (1)
Response to letter regarding article, "Predicting clinical outcomes after thrombolysis using the iScore: results from the Virtual International Stroke Trials Archive". (2013) (1)
Reviewing how we review (2013) (1)
Message from the Editor: On humility (2009) (1)
Counterpoint—Target Aneurysm Recurrence: Measuring What Matters (2015) (1)
Abstract 104: Disability After Minor Stroke and TIA in the POINT Trial (2020) (1)
Waking Up to Narcolepsy (2011) (1)
Healthcare costs: Eden's apple? (2012) (1)
An election season prescription for healthcare (2008) (1)
Acute neurologic symptoms - TIA, migraine, or something else? (2004) (1)
Blockbusters for cheap? The difficulties surrounding generic biologics (2013) (1)
Are relative value units hurting healthcare? (2013) (1)
Percutaneous transluminal coronary angioplasty and endarterectomy were both effective for carotid stenosis (2001) (1)
Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA. Reply. (2020) (1)
Multiple sclerosis: Monotherapy rules (2013) (1)
Scientific literacy and the media (2011) (1)
Statins: not just for the young or the faint of heart. (2009) (1)
Deriving Public Sector Workforce Insights: A Case Study Using Australian Public Sector Employment Profiles (2016) (1)
KO8s are not going to the K‐9s (2007) (1)
Indobufen versus aspirin in patients with acute ischaemic stroke in China (INSURE): a randomised, double-blind, double-dummy, active control, non-inferiority trial (2023) (1)
The Risk and Cost of Limited Clinician and Patient Accountability in Health Care. (2019) (1)
Aligning academic medicine within the healthcare system: the APS-SPR virtual chat series (2022) (1)
American Neurological Association (1875) (0)
Neurology Top Stories for 2010 (2010) (0)
Neuromarketing, and Poker Players Decision Making in Acute Stroke Care: Learning From Neuroeconomics, (2014) (0)
Management of intracranial aneurysms and other vascular malformations (2006) (0)
Erratum: Safety and feasibility of a CT protocol for acute stroke: Combined CT, CT angiography, and CT perfusion imaging in 53 consecutive patients (American Journal of Neuroradiology (April 2003) 24:4 (688-690)) (2003) (0)
Nonstroke Treatment—Reply (2006) (0)
Abstract P043: National Trends in Hypertension Control 1999-2012 and Projected Impact on Incident Stroke by Age, Sex, and Race: The Cardiovascular Disease Policy Model (2014) (0)
Antithrombotics Underused After Stroke and TIA (2004) (0)
Thanks to Our Authors, Reviewers and Publisher (2011) (0)
Re-constructing psychology for women (1988) (0)
Rationale and design of a randomised double-blind 2×2 factorial trial comparing the effect of a 3-month intensive statin and antiplatelet therapy for patients with acute mild ischaemic stroke or high-risk TIA with intracranial or extracranial atherosclerosis (INSPIRES) (2023) (0)
Journeys in Complex Genetics: Music and Mental Illness (2009) (0)
Newly Diagnosed Atrial Fibrillation After Transient Ischemic Attack Versus Minor Ischemic Stroke in the POINT Trial (2021) (0)
Subject Index Vol. 22, 2006 (2006) (0)
Review: statins reduce stroke but not stroke mortality (2005) (0)
Disparities in care: Guilty until proven innocent (2009) (0)
Neurology: Violence at home (2013) (0)
Progress report on the Annals (2009) (0)
Apping at the Annals (2012) (0)
Investigator balkanization (2008) (0)
Immune Response to Cerebral Ischemia To Identify Ischemic Transient Neurological Events (IN3-1.002) (2012) (0)
Prognosis in Neurology (1999) (0)
Medical prizes: Lifetime achievement awards or engines for progress? (2007) (0)
Neurology Outcomes Research Meeting, Sunday, October 19, 2003: Abstracts: Poster sessions (2003) (0)
Response to Letter by Nguyen and Raymond (2008) (0)
Reply (2011) (0)
Gillum and Johnston Institutional Predictors of Ischemic Stroke Outcomes 2139 (2001) (0)
Abstract TMP16: Efficacy and Safety of Ticagrelor in Relation to Time to Loading Dose in the SOCRATES Trial (2017) (0)
Are racial differences in antihypertensive responsiveness reflected in usage after stroke? (2006) (0)
Risk of unruptured aneurysm treatment in California (2000) (0)
Abstract EP63: Recurrent Ischemic Stroke And Cigarette Smoking: A Secondary Analysis Of The Point Trial (2022) (0)
Racism and tPA use in African-Americans [1] (multiple letters) (2001) (0)
Smartphone imaging repository: a novel method for creating a CT image bank (2023) (0)
The urgency of stroke prevention after TIA (2008) (0)
Impact of CYP2C19 polymorphism in prognosis of minor stroke or TIA patients with declined eGFR on dual antiplatelet therapy: CHANCE substudy (2018) (0)
The Upcoming Meeting of the ANA (2007) (0)
Abstract 39: Timing Of Infection And Risk Of Arterial Ischemic Stroke In Children (2012) (0)
Abstract 155: Treatment Outcomes After Regionalization of Acute Stroke Care (2012) (0)
PCV22 Estimating the Reduction in Medical Care Costs Associated with Ticagrelor and Aspirin in Patients with Acute Ischemic Stroke or TIA (2021) (0)
Stroke mortality in the Seychelles: methodological issues – Authors' reply (2009) (0)
Abstract TMP93: Level of Renal Function and Short-term Risk of Recurrent Stroke (2013) (0)
Stroke Association Between Major Perioperative Hemorrhage and Stroke or Q-Wave Myocardial Infarction (2012) (0)
Abstract 60: Inpatient Statin Use in Intracerebral Hemorrhage is Strongly Associated With Improved Survival (2014) (0)
Abstract P592: Admission Hyperglycemia is Associated With Subsequent Ischemic Stroke After Transient Ischemic Attack or Minor Stroke: A Secondary Analysis of the POINT Trial (2021) (0)
No rebound effect after a course of clopidogrel in patients with acute TIA or minor stroke (2022) (0)
Eculizumab in Atypical Hemolytic-Uremic Syndrome (2013) (0)
New Neurology Case with Video (2014) (0)
Genotype‐Guided Dual Antiplatelet Use for Transient Ischemic Attack and Minor Stroke by Imaging Status: Subgroup Analysis of the CHANCE‐2 Trial (2022) (0)
Have the Annals editors added value? (2013) (0)
Are Outcomes of Ischemic Strokes Improved When a Neurologist is Attending (2000) (0)
Living in the time of sequestration (2013) (0)
Saposnik and Johnston Decision Making in Acute Stroke Care 2149 Succumbing to the Temptation : LowBall Technique (2014) (0)
RAPID DEVELOPMENT OF GIANT FUSIFORM CEREBRAL ANEURYSMS IN ANGIOGRAPHICALLYNORMAL VESSELS. AUTHORS' REPLY (1999) (0)
Review: anticoagulants increase intracerebral bleeding and do not reduce death or disability in acute cardioembolic stroke. (2007) (0)
Intraprocedural Rupture of Aneurysms: Not Necessarily a Small Problem (2009) (0)
A randomized, placebo-controlled trial (0)
Cholesterol lowering with simvastatin reduced stroke in patients with, or at risk of, vascular disease (2004) (0)
Why Are So Few Acute Stroke Patients Receiving Tissue Plasminogen Activator Therapy (2006) (0)
Abstract 149: Evaluating the Risk of Cerebrovascular Events Among Those Seeking Information on Transient Ischemic Attack Symptoms on the Internet (2012) (0)
Transient Ischemic Attack : A Statement for Healthcare Professionals From the Guidelines for Prevention of Stroke in Patients With Ischemic Stroke (2006) (0)
Abstract 164: Treatment Differences in Acute Stroke By Mode of Transport (2012) (0)
Ticlopidine was not better than aspirin for preventing recurrent stroke in African-Americans with noncardioembolic ischemic stroke. (2004) (0)
Stroke The iScore Predicts Effectiveness of Thrombolytic Therapy for Acute Ischemic (2012) (0)
Nonstroke Treatment: Reply (Letter to the Editor) (2006) (0)
Systems From the American Stroke Association's Task Force on the Development of Stroke Recommendations for the Establishment of Stroke Systems of Care : Recommendations (2013) (0)
Identification, risks, and treatment of transient ischemic attack. (2009) (0)
A Letter to Our Readers (2014) (0)
Diagnosis of patients in STOP Stroke and prevalence of LVO in patients diagnosed with stroke or (2009) (0)
Recommendations: A Statement for Healthcare Professionals From the Detailed Follow-Up to Brain Attack Coalition Comprehensive Stroke Center Metrics for Measuring Quality of Care in Comprehensive Stroke Centers: (2011) (0)
Response to Letter by O'Kelly and Macdonald (2008) (0)
Subsequent ischemic stroke and tobacco smoking: A secondary analysis of the POINT trial (2022) (0)
Dual Antiplatelet Therapy in Transient Ischemic Attack andMinor StrokeWith Different Infarction Patterns Subgroup Analysis of CHANCE Randomized Clinical Trial (2018) (0)
Glaucoma in Infancy and Early Childhood (2009) (0)
Abstract TMP66: Intravenous Thrombolysis is Associated with Lower Risk of Severe Disability and Death among SPAN-100 Positive Acute Ischemic Stroke Patients (2013) (0)
Diagnosis, Workup, Risk Reduction of Transient Ischemic Attack in the Emergency Department Setting: A Scientific Statement From the American Heart Association (2023) (0)
A modified preceptorship experience. (1994) (0)
Abstract TP253: Clopidogrel Pharmacogenetics in the POINT Trial (2019) (0)
Corrigendum to “Observational Study of Contracts Processing at 29 CTSA Sites” (2014) (0)
Analysis of large databases in stroke (2003) (0)
Abstract WP517: Influence of Smoking on CYP2C19 Genetic Variants and Clopidogrel Efficacy in Patients with Minor Stroke or TIA (2019) (0)
ABCD Score May Aid Stroke Risk Stratification After TIA (2005) (0)
Abstract 159: Recurrent Ischemic Stroke And Cigarette Smoking: A Secondary Analysis Of The POINT Trial (2022) (0)
Abstract 41: Acute Seizures and Neurologic Deficits Predict Epilepsy After Pediatric Stroke (2012) (0)
Abstract TMP100: Outpatient Statin Adherence is Associated with Reduced Recurrent Stroke Risk in Patients with or without Atrial Fibrillation (2017) (0)
Abstract T P294: An Electronic Medical Record Order Set Change To Increase In-Hospital Statin Use In Ischemic Stroke Is Associated With Improved Post-Stroke Outcomes (2015) (0)
Abstract TMP57: Disabling Stroke is Uncommon After An Emergency Department Evaluation and Discharge for Dizziness Symptoms (2013) (0)
Abstract 154: Acute Stroke Recognition by Paramedics after Regionalization of Stroke Care: Outcomes Based Study (2012) (0)
Abstract MP4: Ticagrelor Plus Aspirin Versus Aspirin Alone in Acute Ischemic Stroke or TIA - Analysis of Bleeding Events in the THALES Trial (2021) (0)
Efficacy and Safety of Ticagrelor Versus Clopidogrel in Acute Minor Stroke or Transient Ischaemic Attack Patients with Different Intracranial Artery Stenosis Statuses: A Subgroup Analysis of CHANCE-2, A Randomized, Double-Blind, Controlled Trial (2022) (0)
Rates of fracture after stroke in international population-based cohorts. (2005) (0)
Smartphone Imaging Repository: A Novel, Cost-Effective Method For Creating a CT Image Bank (2021) (0)
Preventing cerebrovascular and cardiovascular events after stroke: eprosartan or nitrendipine? (2006) (0)
Cilostazol for Secondary Stroke Prevention (2021) (0)
Abstract WP420: Clopidogrel with Aspirin May be More Effective in Decreasing One-year Stroke Recurrence for Acute Minor Stroke with Watershed Infarcts: Subgroup Analysis of Chance (2017) (0)
Abstract 89: Effects of the Endpoint Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial (2019) (0)
Abstract 2323: Statin Use and Discharge Disposition After Ischemic Stroke Hospitalization (2012) (0)
The Concept of Transient Ischemic Attack-Reply. (2022) (0)
Contents Vol. 22, 2006 (2006) (0)
Response by Wang and Johnston to Letter Regarding Article, "Ticagrelor in Acute Stroke or Transient Ischemic Attack in Asian Patients: From the SOCRATES Trial (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes)". (2017) (0)
Abstract WMP63: Outcomes After Regionalization of Acute Stroke Care: Time Trend Analysis From Multiple Counties in the State of California (2016) (0)
Abstract WMP96: The Iscore Predicts Clinical Response To Thrombolysis: Results From VISTA (2013) (0)
Abstract 6: Treatment Effect of Clopidogrel Plus Aspirin Within 12 Hours of Acute Minor Stroke or TIA (2016) (0)
Abstract 155: Hyperglycemia And Hypertension Predict Subsequent Ischemic Stroke In Patients With Minor Stroke Or TIA Treated With Dual Antiplatelet Therapy: A Post-hoc Analysis Of The POINT Trial (2022) (0)
Abstract TP245: Impact Of A County-wide Prehospital Destination Protocol On Thrombolytic Rates For Acute Ischemic Stroke (AIS) (2013) (0)
Secondary Preventive Medication Persistence and Adherence One-Year After StrokeStroke (copy of NEUROLOGY/2011/379727, keeping 5 of 15 authors): One Year Medication Persistence Following Stroke (2012) (0)
Abstract 2948: Ischemic Transient Neurological Events Identified by Immune Response to Cerebral Ischemia (2012) (0)
Abstract 80: Application of the ABCD2 Score to Assess the Risk of Stroke in Dizzy Patients Presenting to 19 Emergency Departments (2012) (0)
Neurological Complications of Hypertension (2008) (0)
Score in a Rural Village in the Republic of Argentina (2003) (0)
Abstract 59: Presence of Infarct Predicts Recurrence and Efficacy of Dual Antiplatelet Therapy: A Post-Hoc Analysis of the POINT Trial (2021) (0)
Ticagrelor–Aspirin Versus Clopidogrel–Aspirin Among CYP2C19 Loss-of-Function Carriers With Minor Stroke or Transient Ischemic Attack in Relation to Renal Function: A Post Hoc Analysis of the CHANCE-2 Trial (2022) (0)
Abstract 12937: The Risk for Major Bleeding Was Similar in Patients Receiving Ticagrelor or Aspirin After TIA or Acute Ischemic Stroke in the SOCRATES Study (2016) (0)
Predicting the Risk of Stroke After Transient Ischemic Attack (2007) (0)
Abstract WMP61: Vulnerable And Stabilized States After Cerebral Ischemic Events: Implications Of Kinetic Modeling In The POINT, SOCRATES, And THALES Trials (2023) (0)
The role of Aggrenox®/Asasantin® and Actilyse® in stroke management: Discussion and highlights from the Expert Workshop Sessions (2003) (0)
Quo vadis? – peering into the future (2013) (0)
O-025 Geographical influence on aneurysm treatment outcomes and retreatment rates (2012) (0)
Diffusion-Weighted Imaging Could Aid TIA Diagnosis (2003) (0)
O-010 Stent assisted coiling versus coiling of unruptured intracranial aneurysms in the MAPS trial: safety, efficacy, and mid term outcomes (2012) (0)
Disease topics that define the Annals of Neurology: Introspection (2007) (0)
Deciphering the signature injury (2012) (0)
Abstract 3513: Randomized Trial of Outpatient Cardiac Monitoring After Cryptogenic Stroke (2012) (0)
O-037 bioactive vs. bare platinum coils: the maps 5 year results (2015) (0)
Benefits of medical research: Hollywood weighs in (2011) (0)
P-037 Death and disability after coil embolization of ruptured and unruptured aneurysms in the Matrix and Platinum Science (MAPS) trial (2012) (0)
Erratum: Still No Answers for Chronic Fatigue Syndrome (2011) (0)
Malignant middle cerebral artery stroke: Where ischemia meets the scalpel (2010) (0)
Cross-validation of a simple 3-point prediction rule to stratify 7-day stroke risk after TIA (2006) (0)
The Picnic Papers (1983) (0)

This paper list is powered by the following services:

Other Resources About Clay Johnston

en.wikipedia.org

What Schools Are Affiliated With Clay Johnston ?

Clay Johnston is affiliated with the following schools:

Clay Johnston 's Academic­Influence.com Rankings

Clay Johnston 's Degrees

Why Is Clay Johnston Influential?

Clay Johnston 's Published Works

Published Works

Other Resources About Clay Johnston

What Schools Are Affiliated With Clay Johnston ?

Clay Johnston 's AcademicInfluence.com Rankings